Jennifer Oleksiw has spent 25 years inside Eli Lilly, moving from coding systems to reimagining how a pharma giant connects with patients in the real world. […]

The Mechanics of Pharma M&A with Gilead’s Devang Bhuta: Bhuta, Gilead’s SVP of corporate development, sits down with Kinara’s Chase Feiger to address the many myths […]

In his conversation with Kinara co-editor Chase Feiger, Wu outlines Ascendis’ vision for reshaping the rare disease landscape. He discusses the need to lead with empathy […]

In his first podcast appearance since becoming president and CEO of Akari Therapeutics, Gaslightwala lays out his long-term vision for the future of cancer care. He […]

Sage Therapeutics CEO Barry Greene joins the Kinara podcast to shine a light on the need to support mothers experiencing Postpartum Depression – which, incredibly, wasn’t […]

In this exclusive podcast, Jazz Pharmaceuticals CEO Bruce Cozadd sits down with Kinara co-editor Chase Feiger to discuss his company’s efforts to combine the art and […]

In this episode of the Kinara podcast, NewAmsterdam Pharma CEO and founder Dr. Michael Davidson sits down with Kinara co-editor Chase Feiger to discuss the importance […]

Join Alkermes Chairman and CEO Richard Pops in conversation with Kinara’s Chase Feiger, M.D., as they explore innovations and advancements in mental health care. Together, they […]

Exact Sciences CEO Kevin Conroy sits down with Kinara’s Chase Feiger, M.D., to offer an exclusive behind-the-scenes look at how Cologuard is revolutionizing cancer screening – […]